Shuttle Pharmaceuticals Holdings, Inc. - common stock (SHPH)

Shuttle Pharmaceuticals Holdings, Inc. is a biotechnology company focused on advancing innovative solutions for cancer treatment through its development of novel therapeutics

The company specializes in research aimed at improving the effectiveness of existing cancer therapies, particularly by enhancing the response of cancer cells to radiation and chemotherapy. Shuttle Pharmaceuticals is dedicated to leveraging scientific advancements to create new medications that enhance patient outcomes and quality of life, demonstrating its commitment to addressing significant challenges in oncology. Through its proprietary technologies and drug development programs, the company strives to bring transformative therapies to market that can better support cancer patients and their healthcare providers.